January 19, 2021

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Re:	Passage Bio, Inc.
	Registration Statement on Form S-1 (File No. 333-252213)
	Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:30 p.m. Eastern Time, on Thursday, January 21, 2020 or as soon thereafter as practicable.

[Signature page follows]

Very truly yours,
J.P. MORGAN SECURITIES LLC
GOLDMAN SACHS & CO. LLC COWEN AND COMPANY, LLC
As representatives of the Underwriters
J.P. MORGAN SECURITIES LLC
By:	/s/ David Ke
	Name:	David Ke
	Title:	Executive Director
GOLDMAN SACHS & CO. LLC
By:	/s/ Mairin Rooney
	Name:	Mairin Rooney
	Title:	Managing Director
COWEN AND COMPANY, LLC
By:	/s/ Bill Follis
	Name:	Bill Follis
	Title:	Managing Director

[Signature Page to Passage Bio, Inc. Acceleration Request]